Sharps Technology INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Sharps Technology, Inc. shifts its core strategy to a Solana-focused digital asset treasury, reporting a substantial net loss of $282.5 million for the fiscal year ended December 31, 2025.
NASDAQ
Sharps Technology, Inc. files an amendment to its annual report on Form 10-K to include the company's Compensation Recovery Policy.
NASDAQ
Sharps Technology reports a net loss for FY24, focuses on expanding production capacity, and anticipates potential revenue generation in the second half of 2025.
NASDAQ
Sharps Technology, Inc., a medical device company focused on safety syringe technology, reported its full year 2023 results, highlighting strategic partnerships and ongoing efforts to commercialize its product lines.